Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
- PMID: 35838892
- PMCID: PMC9285188
- DOI: 10.1007/s12350-022-03059-5
Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
Keywords: 99mTc-hydroxymethylene diphosphonate; radiopharmaceutical supply; transthyretin cardiac amyloidosis.
Figures



Similar articles
-
Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.J Nucl Cardiol. 2023 Oct;30(5):2215-2221. doi: 10.1007/s12350-022-03128-9. Epub 2022 Nov 9. J Nucl Cardiol. 2023. PMID: 36352088 No abstract available.
-
A case of disappearing amyloid on technetium pyrophosphate scan.J Nucl Cardiol. 2023 Oct;30(5):1986-1991. doi: 10.1007/s12350-023-03316-1. Epub 2023 Jun 20. J Nucl Cardiol. 2023. PMID: 37340232
-
Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.J Cardiol. 2021 Feb;77(2):124-130. doi: 10.1016/j.jjcc.2020.06.019. Epub 2020 Oct 22. J Cardiol. 2021. PMID: 33132078
-
99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis.Radiology. 2023 Feb;306(2):e221082. doi: 10.1148/radiol.221082. Epub 2022 Dec 20. Radiology. 2023. PMID: 36537896 Free PMC article. Review.
-
Cardiac scintigraphy with 99mTc-diphosphonates in cardiac amyloidosis.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):254-266. doi: 10.1016/j.remn.2020.03.007. Epub 2020 Jun 6. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32513587 Review. English, Spanish.
Cited by
-
The Role of Multimodality Imaging in Cardiomyopathy.Curr Cardiol Rep. 2024 Jul;26(7):689-703. doi: 10.1007/s11886-024-02068-9. Epub 2024 May 16. Curr Cardiol Rep. 2024. PMID: 38753290 Free PMC article. Review.
-
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.J Nucl Cardiol. 2023 Dec;30(6):2531-2539. doi: 10.1007/s12350-023-03310-7. Epub 2023 Jun 13. J Nucl Cardiol. 2023. PMID: 37311914
-
Transthyretin cardiac amyloidosis: advances and ambiguities.Heart Fail Rev. 2025 Aug 29. doi: 10.1007/s10741-025-10552-9. Online ahead of print. Heart Fail Rev. 2025. PMID: 40877718 Review.
-
Advances in Cardiac Imaging and Genetic Testing for Diagnosis and Risk Stratification in Cardiomyopathies: 2024 Update.J Clin Med. 2024 Nov 26;13(23):7166. doi: 10.3390/jcm13237166. J Clin Med. 2024. PMID: 39685624 Free PMC article. Review.
References
-
- Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019;26:2065–2123. doi: 10.1007/s12350-019-01760-6. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials